Galderma Pharma to acquire Spirig Pharma - MarketLine Financial Deals

Galderma Pharma to acquire Spirig Pharma

Galderma Pharma to acquire Spirig Pharma - MarketLine Financial Deals
Galderma Pharma to acquire Spirig Pharma
Published Dec 12, 2012
3 pages — Published Dec 12, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Galderma Pharma, S.A., a pharmaceutical company engaged in the development of prescription medications for the treatment of dermatological conditions, has entered into a definitive agreement to acquire Spirig Pharma AG.

  
Source:
Document ID
MA131682_121218
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Galderma Pharma to acquire Spirig Pharma" Dec 12, 2012. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Galderma-Pharma-to-acquire-Spirig-Pharma-2052-90683>
  
APA:
MarketLine Financial Deals. (2012). Galderma Pharma to acquire Spirig Pharma Dec 12, 2012. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Galderma-Pharma-to-acquire-Spirig-Pharma-2052-90683>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.